جست‌وجوی استاد و پژوهشگر

Veronique Seidelمشاهده پروفایل

مدرس ارشد

• Natural Products Chemistry
• Pharmacognosy
• Drug Discovery
• +۵ مورد دیگر

Veronique Seidel is a Senior Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, United Kingdom. She leads research in natural products chemistry and pharmacognosy with applications in pharmaceutical and cosmeceutical development, while teaching MPharm modules including the Year 3 Management of Infection and Infectious Diseases course. Education: Doctor of Philosophy in Phytochemical and Pharmacological studies on some species of Annonaceae, University of Strathclyde (1995-1998, awarded 1999) Research Interests: Dr. Seidel's work focuses on discovering bioactive compounds from global plant and beehive sources (honey/propolis) through ethnopharmacological investigation, purification, structure elucidation, and screening for antitubercular, anti-inflammatory, antibiofilm, and antivirulence properties. Her laboratory integrates traditional natural product chemistry with computational approaches including molecular docking and dynamics simulations to identify novel therapeutic agents. Research Trends: Recent publications demonstrate a strategic shift toward computational-experimental synergy, with 2025 studies targeting bacterial biofilm disruption through regulator proteins (SarA/LasR) and advanced drug delivery systems like dimenhydrinate-cyclodextrin complexes. This reflects her growing emphasis on translating natural product discoveries into clinically relevant antimicrobial and anti-inflammatory applications. Scientific Awards: Faculty of Science Starter Research Award (2003) Fellowship of the Higher Education Academy (FHEA) Award (2011) Life Sciences Prize (French Academy of Pharmacy) Parke-Davis Natural Products Chemistry Prize (French Academy of Pharmacy) Advising and Leadership: Dr. Seidel supervises PhD students and has completed 11 supervised works. She coordinates 20 research projects including the EU COST ACTION MedPlants4Vet and tuberculosis drug discovery initiatives. As founder of the SIPBS-WIDE committee, she led the successful Athena SWAN Silver Award application and previously served as Honorary Treasurer of the Phytochemical Society of Europe (2014-2019). Research Infrastructure: She directs the Natural Products Research Laboratory which utilizes specialized equipment including sample mixers for extraction and purification workflows, focusing on geographical diversity of natural sources to identify novel bioactive molecules.

• Pharmaceutical Science
• Drug Delivery
• Health and Wellbeing
• +۳ مورد دیگر

Elzbieta Maria Buczkowska is a Visiting Researcher at Riga Stradins University, actively contributing to pharmaceutical technology research. She serves as a Lead Researcher Group member and specializes in twin-screw melt granulation for high-drug-loaded immediate-release tablets. Active in 3 projects (2023-2026) Co-authored 5 publications in 2025 Contributed to 9 datasets on polyol characterization Research focuses on sugar alcohols (polyols) as pharmaceutical binders, examining their tensile strength , dissolution rates , and compatibility with effervescent tablet preparation. Her work intersects with the UN Sustainable Development Goal Health and Wellbeing . Recent activities include conference presentations on: Physical stability of solid dispersions Magnesium stearate lubrication effects Design of Experiment methodology training

Alexander Sidorenkoمشاهده پروفایل

استاد

• Polymer Chemistry
• Biomaterials
• Smart Materials
• +۳ مورد دیگر

Professor Alexander Sidorenko serves in the Department of Chemistry and Biochemistry at Temple University, specializing in physico-chemical phenomena at interphases and nanostructured materials. His research focuses on designing "smart" materials with applications spanning molecular electronics to bioengineering. Dr. Sidorenko's research interests center on polymer chemistry and biomaterials, particularly in developing bio-benign molecular brushes and polymer CORALs (Co-Ordinated Responsive Arrays of surface Linked islands). His work employs supramolecular chemistry approaches for 2D and 3D assembly, creating adaptive hybrid materials for biomedical applications including drug delivery systems and tissue engineering scaffolds. Key innovations include chitosan-based comb-like polypeptides with antibiotic properties and solvent-responsive surface architectures. His publication record demonstrates consistent output in high-impact journals including Macromolecules , ACS Applied Materials & Interfaces , and Langmuir , with significant contributions to polymer brush technology and nanostructured materials. The research shows strong interdisciplinary trends, bridging pharmaceutical sciences, materials engineering, and surface chemistry. Dr. Sidorenko actively collaborates with researchers from the Department of Pharmaceutical Sciences and the West Center for Computational Chemistry and Drug Design. His laboratory develops novel synthetic methodologies for creating adaptive hybrid molecular brushes composed of biopolymers like chitosan with synthetic polymers including polylactide and poly(N-vinyl pyrrolidone), focusing on applications for guiding human dermal fibroblasts and antimicrobial activity.

David Jonesمشاهده پروفایل

استاد

• Pharmaceutical Science
• Drug Delivery
• Biomaterials
• +۹ مورد دیگر

David Jones is a Professor at the School of Pharmacy Material and Advanced Technologies for Healthcare at Queen's University Belfast, United Kingdom. His research focuses on pharmaceutical sciences, biomaterials, and advanced drug delivery systems. He actively supervises PhD students and contributes to drug delivery innovation. Accepting PhD Students Research Areas: Drug Delivery, Biomaterials, Polymer Science, 3D Printing Technology Professor Jones has developed biocompatible implants for post-surgery pain control, mucoadhesive platforms for oral drug delivery, and advanced manufacturing techniques like hot-melt extrusion and 3D printing. His work spans therapeutic deep eutectic solvents , amorphous solid dispersions , and anti-infective biomaterials . His recent publications highlight trends in superhydrophobic materials for medical devices, hydrogel coatings , controlled release implants , and 3D-printed dosage forms . Articles emphasize polymer science applications in pharmaceuticals and thermal analysis for optimizing drug formulations. Scientific Awards Chapman Medal of the Institute of Materials, Minerals and Mining (2024) Griffith Medal of the Institute of Materials, Minerals and Mining (2019) Academy of Pharmaceutical Sciences Award Lecture (2023) Eli Lilly Award for Pharmaceutical Excellence (1997) British Pharmaceutical Conference Science Medal (1997) As a key investigator in projects like MICA: EnLAmB and KTP collaborations , Professor Jones leads advancements in affordable liposomal amphotericin B formulations and drug delivery technologies. His work has significant health and economic impacts , including the development of Cohesive Paste™ for stoma patients.

Ann-Christin Pöpplerمشاهده پروفایل

استاد

• NMR Spectroscopy
• Solid-state NMR
• Drug-polymer formulations
• +۵ مورد دیگر

Prof. Ann-Christin Pöppler is a Professor of Organic Structural Chemistry at the University of Würzburg, Faculty of Chemistry and Pharmacy, Institute of Organic Chemistry. She leads an active research group focused on NMR spectroscopy to investigate drug-polymer formulations and structural chemistry in biologically relevant environments. Her research centers on understanding drug molecules and their interactions in solid state and solution, synthesis and analysis of polymer platforms/hydrogels, and studying drug-matrix interactions for controlled release applications. Her group employs a versatile toolbox including 1D and 2D NMR in isotropic and anisotropic environments, diffusion NMR, solid-state NMR at various MAS speeds combined with DFT calculations and diffraction methods, DSC, and TGA. Prof. Pöppler's research spans multiple disciplines with a strong emphasis on pharmaceutical applications, materials science, and structural characterization. Her work demonstrates how NMR techniques can provide molecular-level insights into complex drug delivery systems, particularly focusing on how drugs interact with polymer matrices and biological environments. Her scientific contributions show a consistent focus on structural chemistry with applications in drug delivery, particularly examining poly(2-oxazoline) systems, bile-drug interactions, and advanced NMR methodologies for characterizing complex formulations. The publications reveal strong collaborative networks across European institutions. Prof. Pöppler actively mentors students at all levels, with numerous PhD, Master's, and Bachelor's students completing research in her group. Recent graduates have secured positions at companies like BASF and Siemens Healthineers or continued academic careers. Her laboratory combines NMR spectroscopy with complementary methods such as PXRD and quantum chemical calculations (CASTEP/GIPAW). The group utilizes 400 MHz and 600 MHz spectrometers for solution NMR and solid-state NMR capabilities up to 60 kHz magic angle spinning. They also conduct organic synthesis of drug derivatives and modified polymers to support their structural characterization work.

Jyrki Tapio Heinämäkiمشاهده پروفایل

استاد

• Pharmaceutical Nanotechnology
• Drug Delivery Systems
• Oral Solid Dosage Forms
• +۴ مورد دیگر

Dr. Jyrki Tapio Heinämäki is a Professor of Pharmaceutical Nanotechnology and Program Director of the doctoral program in pharmacy at the University of Tartu , Institute of Pharmacy. He holds a permanent honorary Visiting Professor position at the University of Havana, Cuba, since 2008. His academic career spans institutions in Finland and Estonia, with appointments including Associate Professor at the University of Helsinki (1995) and a five-year term as Professor of Medical Technology at the University of Tartu (2010–2015). Dr. Heinämäki's research focuses on pharmaceutical nanotechnology and oral solid dosage forms , particularly powder technology , nanofiber fabrication , granulation , tableting , polymer coatings , and surface treatment of solid drug substances . His group develops nanotechnology-based solutions for improving solubility of poorly water-soluble drugs, multifunctional nanofibrous drugs for wound healing, electrospinning techniques , printed nanomaterial substrates for personalized pharmacotherapy, and formulations for natural products . They also advance Process Analytical Technologies (PAT) for pharmaceutical nanotechnology. With over 125 peer-reviewed articles (category 1.1) and 25 conference abstracts , Dr. Heinämäki has supervised or co-supervised 20 doctoral theses . His work bridges academic research and industrial pharmacy, including consultancy on drug marketing authorization applications. Formal details of his CV and publications are available via the Estonian Research Information System (ETIS).

Andres Meosمشاهده پروفایل

دانشیار

• Pharmaceutical Chemistry
• Chemical Analysis
• Pharmaceutical Analysis
• +۳ مورد دیگر

Associate Professor Andres Meos has been a member of the Faculty of Medicine at the University of Tartu since 1984, currently serving as Associate Professor of Pharmaceutical Chemistry within the Institute of Pharmacy. His career spans over four decades, progressing from assistant to associate professor, and he has been instrumental in teaching and research in pharmaceutical chemistry and chemical analysis. Education Tartu 7th Secondary School, 1975 Tartu State University, Faculty of Pharmacy, 1981 PhD (Candidate of Biological Sciences in Pharmacology), Institute of Pharmacology, USSR Academy of Medical Sciences, Moscow, 1986 Research Interests Andres Meos focuses on pharmaceutical chemistry , chemical analysis , and drug delivery systems . His research integrates advanced analytical techniques, nanotechnology, and formulation science to develop innovative dosage forms and therapeutic strategies. Key themes include: 3D printing and extrusion-based fabrication of personalized pharmaceuticals Electrospinning of fibrous matrices for antimicrobial and wound-healing applications Stability and quality control of bioactive compounds in nutraceuticals and pharmaceuticals Development of biorelevant assays for multifunctional wound dressings Publication Trends Meos’s recent publications (2020-2025) demonstrate a clear trajectory toward advanced manufacturing technologies in pharmaceutics, particularly 3D printing and electrospinning , alongside rigorous analytical method development . His work spans from fundamental formulation studies to translational applications in wound care and personalized medicine. Grants & Projects He actively participates in the Estonian Research Council–funded project “Development of biorelevant assays for the analyses of multifunctional antimicrobial wound dressings for the treatment of wound infections” (PRG1507, €760,450, 2022-2026). Laboratory & Collaborations Meos collaborates extensively with national and international partners, including Nordic POP and the 14th World Meeting on Pharmaceutics, fostering interdisciplinary research in drug delivery and pharmaceutical technology.

• targeted drug delivery
• preclinical pharmacology
• molecular imaging
• +۴ مورد دیگر

Prof. Dr. Steffi Lehmann serves as Professor and Head of the Department of Pharmaceutical Technology and Pharmacology at Zurich University of Applied Sciences (ZHAW), School of Life Sciences and Facility Management, while also leading the MSc Pharmaceutical Biotechnology program. Her research focuses on: Targeted drug delivery systems development Preclinical pharmacology using 2D/3D cell cultures and zebrafish larvae for DMPK and efficacy testing In vitro/in vivo molecular imaging techniques Pharmaceutical formulation engineering Current projects include zebrafish-based drug screening, brain cancer drug retention strategies, and novel phage-derived antimicrobials. Completed projects span CAR macrophage efficacy imaging, antimicrobial surface coatings, and diagnostic tablet formulations. Recent publications demonstrate expertise in antimicrobial lysin engineering and extracellular vesicle functionalization, bridging nanotechnology with therapeutic delivery applications. She contributes to continuing education through the CAS Detergents & Cosmetics program.

Katja Nussمشاهده پروفایل

پژوهشگر

• Musculoskeletal Research
• Intracranial Aneurysms
• Wound Healing Enhancement
• +۳ مورد دیگر

Dr. Katja Nuss is a senior researcher and co-leader of the Musculoskeletal Research Unit (MSRU) at the Vetsuisse Faculty, University of Zurich. She specializes in veterinary surgery and anesthesiology, with extensive experience in clinical and experimental surgery. The MSRU focuses on musculoskeletal research, including bone/cartilage healing, tendon repair, muscle degeneration, and spine surgery, with GLP accreditation for preclinical studies. Specializes in intracranial aneurysm research using animal models Investigates wound healing enhancement and biomaterials Collaborates with Prof. Simon Hoerstrup on heart valve replacement The unit employs advanced diagnostic imaging (MRI, angiography) and maintains a herd of 250 sheep for experimental studies. She received the Neer Award 2016 for rotator cuff injury research. The MSRU team includes 20 members, with a focus on biocompatibility testing, implant integration, and novel surgical technologies.

Florian Prieseمشاهده پروفایل

استاد

• Pharmaceutical Engineering
• Drug Delivery Systems
• Fluidized Bed Technology
• +۴ مورد دیگر

Professor Florian Priese serves as faculty at Anhalt University of Applied Sciences within the Department of Applied Biosciences and Process Engineering. His institutional roles include Professor and Temporary Lecturer positions, along with serving as Degree Program Advisor for the Master of Science in Pharmaceutical Engineering (available as both full-time and dual study options). His office is located in Building 73 (Junkers Building), 3rd floor, Room 308 at the Köthen campus. Professor Priese's research focuses on pharmaceutical engineering with particular expertise in drug delivery systems, especially multiparticulate systems like pellets and mini-tablets. His work spans pharmaceutical analysis, quality assurance, and process engineering, with a strong emphasis on fluidized bed technology for coating applications. He investigates controlled drug release mechanisms, particle size measurement techniques, and process analytical technology for pharmaceutical manufacturing. Analysis of Professor Priese's publication record from 2013-2024 reveals a consistent research trajectory in pharmaceutical technology, with recent work focusing on advanced drug delivery systems and process control. His publications demonstrate expertise in fluidized bed coating technologies, particle engineering, and quality by design approaches in pharmaceutical manufacturing, showing progression from fundamental investigations to more advanced applications involving real-time process monitoring. Pharmaceutical Analysis and Quality Assurance (core responsibility) Fluidized Bed Coating Technologies Drug Delivery Systems Development Process Analytical Technology Implementation As Degree Program Advisor for the Pharmaceutical Engineering Master's program, Professor Priese oversees student mentorship and curriculum development. His dual role as both Professor and Temporary Lecturer suggests significant teaching responsibilities across multiple courses within the pharmaceutical engineering curriculum. The Department of Applied Biosciences and Process Engineering where Professor Priese works likely maintains specialized laboratory facilities supporting research in pharmaceutical technology, including fluidized bed processing equipment, particle characterization instruments, and formulation development capabilities that serve both research and educational purposes.

• Pharmacy
• Analytical Chemistry
• Metabolomics
• +۳ مورد دیگر

Juho Heininen is a Doctoral Researcher at the Department of Pharmaceutical Biosciences , University of Helsinki, Finland. He is affiliated with the Doctoral Programme in Drug Research and contributes to interdisciplinary projects bridging pharmaceutical sciences with agricultural biotechnology. PhD candidate in Pharmaceutical Chemistry Active in chemical proteomics and metabolomics research Research Focus: His work spans three primary areas: Development of isobaric labeling techniques for metabolite quantitation in single cells Exploration of dairy industry byproducts in pharmaceutical manufacturing Investigation of photosynthetic adaptations in indoor crop production systems Publication Trends: Over 2021-2025, Heininen has published 5 peer-reviewed articles focusing on analytical methodology, drug delivery systems, and plant-pharma intersections. His recent work emphasizes precision agriculture applications of pharmaceutical research tools. Advising & Grants: He supervised Sara Kavilo's BSc thesis and participates in two funded projects: Akatemiahanke Chemical proteomics (Academy of Finland, 2024-2028) Orion Research Foundation project (2023-2024)

Ivan Kassamakovمشاهده پروفایل

دانشیار

• Optics
• Scattering
• Particle Physics
• +۲ مورد دیگر

Ivan Kassamakov serves as a Docent (Associate Professor) in the Department of Physics at the University of Helsinki, where he supervises doctoral candidates in both the Materials Research and Nanosciences and Particle Physics and Universe Sciences programmes. His academic profile is anchored in experimental physics with strong institutional ties to the university's research infrastructure. His research centers on advanced optical methodologies, particularly light scattering phenomena and instrumentation development. Key focus areas include particulate media analysis through electromagnetic wave interactions, nanoscale microscopy enhancement, and biomedical applications of optical techniques. This work bridges fundamental physics with translational applications in materials science and medical engineering, evidenced by innovations like the 4 pi Scatterometer for comprehensive scattering measurements and micro-devices for sub-diffraction resolution microscopy. Recent publication trends reveal a strategic expansion into interdisciplinary domains, with growing emphasis on biomedical engineering applications. His 2023-2025 outputs demonstrate convergence of optical physics with pharmaceutical technology (3D-printed pediatric medications) and biomaterials science (bone growth analysis using acoustic microscopy). This evolution reflects a deliberate shift toward solving clinically relevant problems while maintaining core expertise in scattering physics and optical instrumentation. Kassamakov actively participates in major collaborative research initiatives, most notably the ERC Advanced Grant project SAEMPL (Scattering and Absorption of Electromagnetic Waves in Particulate Media), where he contributed to scattering theory development and instrumentation. His supervisory role in two doctoral programmes underscores his commitment to training next-generation researchers in specialized physics domains. Current projects indicate sustained focus on instrumentation development for both fundamental research and medical applications. He maintains strong collaborative networks across physics and biomedical engineering disciplines, particularly evident in co-authored works involving scanning acoustic microscopy, vacuum plasma applications, and 3D pharmaceutical printing. These partnerships span multiple research groups within the university, reflecting his position at interdisciplinary research intersections.

Jukka Rantanenمشاهده پروفایل

استاد

• Process Analytical Technology (PAT)
• Pharmaceutical Manufacturing
• Solid-state Chemistry
• +۴ مورد دیگر

Jukka Rantanen serves as Professor and Head of the Department of Pharmacy within the Faculty of Health and Medical Sciences at the University of Copenhagen. Since joining the faculty in 2006 after postdoctoral training at Purdue University, he has established leadership roles including Chairman of the EUFEPS QbD and PAT Sciences Network Steering Committee and membership in the European Pharmacopoeia Commission's Process Analytical Technology Working Party. Education: Docent in Physical Pharmacy, University of Helsinki (2001) PhD in Pharmacy, University of Helsinki (2001) Research Focus: Professor Rantanen pioneers Process Analytical Technology (PAT) and innovative pharmaceutical manufacturing , with expertise spanning solid-state chemistry , crystallization science , and data-driven drug production . His work bridges additive manufacturing (3D printing of combination drugs), blockchain security for medications , and advanced granulation processes , driving industry adoption of Quality by Design principles. Research Trends: Recent publications (2023-2025) demonstrate intensified focus on computational approaches (CSD data mining for hydrate prediction), personalized medicine stability challenges, and manufacturing robustness. His team actively develops blockchain-based authentication systems while optimizing twin-screw granulation parameters for commercial-scale production. Scientific Recognition: APV Research Award for Outstanding Achievements in Pharmaceutical Sciences (2016) Academic Leadership: With supervision of 40+ PhD students and editorial roles at leading pharmaceutical journals, Rantanen shapes next-generation scientists. His research attracts significant industry funding through collaborations with 20+ international companies, particularly in solid-state chemistry consulting and litigation support. Former service on Denmark's Council for Independent Research (2013-2018) highlights policy influence. Research Infrastructure: Leads a multidisciplinary team at Copenhagen investigating real-time process monitoring, crystallization control, and 3D-printed drug products. Current projects include EUFEPS network initiatives advancing PAT implementation across European pharmaceutical manufacturing facilities.

Natalja Geninaمشاهده پروفایل

دانشیار

• Personalized Medicine
• Pharmaceutical Printing Technologies
• Drug Delivery Systems
• +۳ مورد دیگر

Natalja Genina serves as Associate Professor in the Department of Pharmacy at the University of Copenhagen, specializing in personalized pharmaceutical manufacturing and drug delivery innovation. Her work bridges cutting-edge production technologies with healthcare system integration. Her educational foundation includes: Ph.D. in Pharmaceutical Technology from University of Helsinki (2010) M.Sc. in Pharmacy from University of Tartu (2006) Research centers on developing personalized dosage forms through printing technologies, non-destructive quality control systems, and digital platforms for on-demand drug production in pharmacies, industries, or homes. She investigates regulatory and societal impacts through interdisciplinary collaboration with Social and Clinical Pharmacy researchers, focusing on patient-oriented products and controlled drug delivery systems. Recent publications (2024-2025) demonstrate dominant trends in 3D pharmaceutical printing, particularly binder jetting and fused deposition modeling for patient-tailored products. Key themes include microstructure analysis of printed tablets, stability of antidepressant formulations, near-infrared/Raman imaging for quality assessment, and QR-encoded smart dosage systems - reflecting convergence of material science, precision medicine, and digital health. She mentors MSc and PhD students through problem-based learning and research integration, with many MSc students publishing papers before graduation. Her teaching philosophy emphasizes student ownership of ideas and active critical thinking through case studies and collaborative problem-solving. Leading the Pharmaceuticals, processes and products research group, she maintains international collaborations focused on translating personalized medicine concepts into practical healthcare solutions while addressing regulatory and distribution challenges.

Else Skovgaard Holmfredمشاهده پروفایل

پژوهشگر

• Analytical Chemistry
• Pharmaceutical Science
• Isotopic Analysis
• +۵ مورد دیگر

Else Skovgaard Holmfred is a Postdoctoral Researcher at Stanford University's Department of Pharmacy within the School of Medicine. She specializes in advanced analytical chemistry applications in pharmaceutical science, with expertise in ICP-MS, mass spectrometry, HPLC, DLS, and multivariate data analysis. Her work focuses on developing innovative pharmaceutical methodologies using isotopic and trace elemental analysis to detect non-visual drug counterfeits. Her educational background includes: Ph.D. in Pharmaceutical Sciences from Technical University of Denmark (2018-2022) M.Sc. in Pharmaceutical Sciences from University of Copenhagen (2015-2017) B.Sc. in Pharmacy from University of Copenhagen (2011-2014) Dr. Holmfred's research integrates biogeochemistry with pharmaceutical science to create novel approaches for drug authentication. Her work spans isotopic analysis of pharmaceutical products, trace element fingerprinting, nanomaterial characterization, and pharmaceutical excipient studies. She employs sophisticated analytical techniques to address critical issues in drug quality and safety, with particular emphasis on detecting counterfeit medications that cannot be identified through visual inspection. Her publication record demonstrates consistent output in high-impact journals, showing a clear trajectory from nanomaterial dissolution studies toward increasingly sophisticated pharmaceutical authentication methods. Recent work focuses on isotopic patterns in drug products (2025), trace element analysis in ibuprofen (2024), and protein compaction properties (2024), reflecting her evolving expertise at the intersection of analytical chemistry and pharmaceutical science. Scientific recognition includes: Carlsberg Foundation Internationalisation Fellowship (2022) Novo Nordisk Foundation Visiting Scholar Stanford Bio-X Fellowship (2023) Her research has garnered significant attention, being picked up by 10 news outlets, referenced in policy sources, and blogged about extensively. She conducts her research in the Chamberlain lab at Stanford University, where she applies biogeochemical approaches to pharmaceutical challenges. Her work has practical implications for drug safety and quality control, with potential applications in regulatory science and pharmaceutical manufacturing.